Infection and Its Impact on Psoriasis: a Systematic Review and Meta-analysis

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2024 Dec 23

PMID 39712183

Authors

Yijiao Yan

Wenhui Deng

Chengzhi Shi

Jiaxin Xie

Daoshun Sui

Affiliations

Soon will be listed here.

Abstract

Introduction: Psoriasis is a chronic skin condition characterized by immune-mediated inflammation. Recent research suggests a possible interaction between infection and the immunopathogenesis of psoriasis. However, over the past 5 years, no significant new evidence has clarified the relationship between and skin diseases. This study aimed to determine the relationship between infection and psoriasis through a systematic review and meta-analysis.

Methods: We searched for articles published in databases including PubMed, Embase, the China National Knowledge Infrastructure, and Web of Science up to January 1, 2024. Statistical analyses were conducted using Review Manager 5.3 and Stata 12.0 software.

Results: Our search yielded 271 papers. After rigorous screening by multiple reviewers, 15 studies involving 2,427 individuals were included. The odds ratio for infection was significantly higher in the psoriasis group than in the control group (odds ratio = 1.94, 95% confidence interval: 1.40-2.68,  < 0.0001). Subgroup analysis revealed no significant differences in infection rates between Asia and Europe. The type of study also did not significantly affect infection rates. The enzyme-linked immunosorbent assay detected infection at a significantly higher rate than the breath test. Furthermore, the prevalence of infection differed significantly between patients with moderate-to-severe psoriasis and those with mild psoriasis.

Conclusion: Our findings suggest a relationship between psoriasis and infection, with variations observed based on geography, testing methods, and disease severity. These findings hold significant potential for guiding clinical practice.

Systematic Review Registration: http://www.crd.york.ac.uk/, identifier CRD42022359427.

References

Malfertheiner P, Camargo M, El-Omar E, Liou J, Peek R, Schulz C . Helicobacter pylori infection. Nat Rev Dis Primers. 2023; 9(1):19. PMC: 11558793. DOI: 10.1038/s41572-023-00431-8. View

Ribaldone D, Saracco G, Pellicano R . Comment on Helicobacter pylori seroprevalence and the occurrence and severity of psoriasis. An Bras Dermatol. 2017; 92(4):584. PMC: 5595620. DOI: 10.1590/abd1806-4841.2017112. View

Yu M, Zhang R, Ni P, Chen S, Duan G . Infection and Psoriasis: A Systematic Review and Meta-Analysis. Medicina (Kaunas). 2019; 55(10). PMC: 6843633. DOI: 10.3390/medicina55100645. View

Magen E, Delgado J . Helicobacter pylori and skin autoimmune diseases. World J Gastroenterol. 2014; 20(6):1510-6. PMC: 3925859. DOI: 10.3748/wjg.v20.i6.1510. View

Griffiths C, van der Walt J, Ashcroft D, Flohr C, Naldi L, Nijsten T . The global state of psoriasis disease epidemiology: a workshop report. Br J Dermatol. 2017; 177(1):e4-e7. PMC: 5600082. DOI: 10.1111/bjd.15610. View

Orsmond A, Bereza-Malcolm L, Lynch T, March L, Xue M . Skin Barrier Dysregulation in Psoriasis. Int J Mol Sci. 2021; 22(19). PMC: 8509518. DOI: 10.3390/ijms221910841. View

Lo C, Mertz D, Loeb M . Newcastle-Ottawa Scale: comparing reviewers' to authors' assessments. BMC Med Res Methodol. 2014; 14:45. PMC: 4021422. DOI: 10.1186/1471-2288-14-45. View

Menter A, Strober B, Kaplan D, Kivelevitch D, Prater E, Stoff B . Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol. 2019; 80(4):1029-1072. DOI: 10.1016/j.jaad.2018.11.057. View

Hernando-Harder A, Booken N, Goerdt S, Singer M, HARDER H . Helicobacter pylori infection and dermatologic diseases. Eur J Dermatol. 2009; 19(5):431-44. DOI: 10.1684/ejd.2009.0739. View

10.

Fabrizi G, Carbone A, Lippi M, Anti M, Gasbarrini G . Lack of evidence of relationship between Helicobacter pylori infection and psoriasis in childhood. Arch Dermatol. 2001; 137(11):1529. View

11.

Dauden E, Penas P, Pajares J, Garcia-Diez A . Association of Helicobacter pylori infection with psoriasis and lichen planus: prevalence and effect of eradication therapy. Arch Dermatol. 2000; 136(10):1275-6. DOI: 10.1001/archderm.136.10.1275. View

12.

Salvatori S, Marafini I, Laudisi F, Monteleone G, Stolfi C . and Gastric Cancer: Pathogenetic Mechanisms. Int J Mol Sci. 2023; 24(3). PMC: 9917787. DOI: 10.3390/ijms24032895. View

13.

Tshibangu-Kabamba E, Yamaoka Y . Helicobacter pylori infection and antibiotic resistance - from biology to clinical implications. Nat Rev Gastroenterol Hepatol. 2021; 18(9):613-629. DOI: 10.1038/s41575-021-00449-x. View

14.

Bardazzi F, Magnano M, Fiorini G, Vaira D, Odorici G, Bertusi G . Helicobacter pylori infection in psoriatic patients during biological therapy. Ital J Dermatol Venerol. 2020; 156(5):570-574. DOI: 10.23736/S2784-8671.19.06410-1. View

15.

Mezmale L, Coelho L, Bordin D, Leja M . Review: Epidemiology of Helicobacter pylori. Helicobacter. 2020; 25 Suppl 1:e12734. DOI: 10.1111/hel.12734. View

16.

Ayala-Fontanez N, Soler D, McCormick T . Current knowledge on psoriasis and autoimmune diseases. Psoriasis (Auckl). 2018; 6:7-32. PMC: 5683130. DOI: 10.2147/PTT.S64950. View

17.

Qayoom S, Ahmad Q . Psoriasis and Helicobacter pylori. Indian J Dermatol Venereol Leprol. 2007; 69(2):133-4. View

18.

Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M . Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015; 350:g7647. DOI: 10.1136/bmj.g7647. View

19.

Boehncke W, Schon M . Psoriasis. Lancet. 2015; 386(9997):983-94. DOI: 10.1016/S0140-6736(14)61909-7. View

20.

Onsun N, Arda Ulusal H, Su O, Beycan I, Ozkaya D, Senocak M . Impact of Helicobacter pylori infection on severity of psoriasis and response to treatment. Eur J Dermatol. 2011; 22(1):117-20. DOI: 10.1684/ejd.2011.1579. View